BioSpace News Archive

Business

Myomo Reports Third Quarter 2019 Results

Growth Metrics Accelerating; Timing of Insurance Payments Affecting Short-term Revenue Growth

November 12, 2019
·
11 min read
Business

Equillium Announces Leadership Updates

Effective January 1, 2020 Bruce Steel will assume role of Chief Executive Officer, and Dan Bradbury will remain on the Board of Directors as Executive Chairman

November 12, 2019
·
7 min read
Deals

Replimune Announces Proposed Public Offering

Replimune Group, Inc., a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, announced a proposed public offering of up to 5,000,000 shares of its common stock.

November 12, 2019
·
4 min read
Business

Omeros Corporation Reports Third Quarter 2019 Financial Results

Omeros Corporation announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2019.

November 12, 2019
·
15 min read
Business

Health Catalyst Reports Third Quarter 2019 Results

Health Catalyst, Inc., a leading provider of data and analytics technology and services to healthcare organizations, reported financial results for the third quarter ended September 30, 2019.

November 12, 2019
·
19 min read
Deals

Shockwave Announces Proposed Public Offering of Common Stock

Shockwave Medical, Inc. announced it has commenced an underwritten public offering of $75,000,000 of shares of its common stock. All of the shares of common stock are being offered by Shockwave.

November 12, 2019
·
4 min read
Deals

Halozyme Therapeutics, Inc. Announces Proposed Offering of $400 Million of Convertible Senior Notes due 2024

Halozyme Therapeutics, Inc. announced that it intends to offer, subject to market conditions and other factors, $400 million aggregate principal amount of convertible senior notes due 2024.

November 12, 2019
·
5 min read
Job Trends

Hanger to Present at Upcoming Investor Conferences in November and December 2019

Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced that members of its management team will participate in presentations and meetings with institutional investors at the following conferences:

November 12, 2019
·
2 min read
Business

Vaxart Announces Third Quarter 2019 Financial Results and Provides Corporate Update

$9 million Underwritten Public Offering Closed

November 12, 2019
·
8 min read
Deals

EXMceuticals Provides Bi-Weekly Default Status Report

EXMceuticals Inc. is providing this bi-weekly default status report in accordance with National Policy 12-203 Management Cease Trade Orders (“NP 12-203”).

November 12, 2019
·
3 min read